<VariationArchive VariationID="2500781" VariationName="NM_000252.2(MTM1):c.-76_-11del" VariationType="Deletion" Accession="VCV002500781" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-29" DateCreated="2023-05-07" MostRecentSubmission="2023-05-06">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2523678" VariationID="2500781">
      <GeneList>
        <Gene Symbol="LOC130068796" FullName="ATAC-STARR-seq lymphoblastoid silent region 21050" GeneID="130068796" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="150568423" stop="150569102" display_start="150568423" display_stop="150569102" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="MTM1" FullName="myotubularin 1" GeneID="4534" HGNC_ID="HGNC:7448" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="150562653" stop="150673143" display_start="150562653" display_stop="150673143" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="149737046" stop="149841615" display_start="149737046" display_stop="149841615" Strand="+" />
          </Location>
          <OMIM>300415</OMIM>
          <Haploinsufficiency last_evaluated="2021-01-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MTM1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-01-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=MTM1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000252.2(MTM1):c.-76_-11del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq28</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="150568597" stop="150568662" display_start="150568597" display_stop="150568662" variantLength="66" positionVCF="150568596" referenceAlleleVCF="CAGAGGGGGCGGAGCAGGGCCCGGCAGCCGAGCAGCCTGGCAACGGCGGTGGCGCCCGGAGCCCGAG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="149737047" stop="149737112" display_start="149737047" display_stop="149737112" variantLength="66" positionVCF="149737046" referenceAlleleVCF="CAGAGGGGGCGGAGCAGGGCCCGGCAGCCGAGCAGCCTGGCAACGGCGGTGGCGCCCGGAGCCCGAG" alternateAlleleVCF="C" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.149737047_149737112del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.149737047_149737112del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.150568597_150568662del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.150568597_150568662del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008199.1" sequenceAccession="NG_008199" sequenceVersion="1" change="g.5001_5066del">
            <Expression>NG_008199.1:g.5001_5066del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0002153" Type="genic upstream transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_203210.1" sequenceAccession="NG_203210" sequenceVersion="1" change="g.275_340del">
            <Expression>NG_203210.1:g.275_340del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0002153" Type="genic upstream transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_839" sequenceAccession="LRG_839">
            <Expression>LRG_839:g.5001_5066del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_839t1" sequenceAccession="LRG_839t1">
            <Expression>LRG_839t1:c.-76_-11del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000252.2(MTM1):c.-76_-11del AND Severe X-linked myotubular myopathy" Accession="RCV003225693" Version="9">
        <ClassifiedConditionList TraitSetID="1981">
          <ClassifiedCondition DB="MedGen" ID="C0410203">Severe X-linked myotubular myopathy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-05-07" MostRecentSubmission="2023-05-06">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="1981" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5607" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">MYOTUBULAR MYOPATHY 1</ElementValue>
                <XRef Type="MIM" ID="310400" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Myotubular myopathy, X-linked</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">X-linked centronuclear myopathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Severe X-linked myotubular myopathy</ElementValue>
                <XRef ID="Severe+x-linked+myotubular+myopathy/9289" DB="Genetic Alliance" />
                <XRef ID="46804001" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MTMX</ElementValue>
                <XRef Type="MIM" ID="310400" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">XLMTM</ElementValue>
                <XRef Type="MIM" ID="310400" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">CNMX</ElementValue>
                <XRef Type="MIM" ID="310400" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MTM1</ElementValue>
                <XRef Type="MIM" ID="310400" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="11925" />
                <XRef ID="11925" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">X-linked myotubular myopathy (X-MTM), also known as myotubular myopathy (MTM), is characterized by muscle weakness that ranges from severe to mild. Approximately 80% of affected males present with severe (classic) X-MTM characterized by polyhydramnios, decreased fetal movement, and neonatal weakness, hypotonia, and respiratory failure. Motor milestones are significantly delayed and most individuals fail to achieve independent ambulation. Weakness is profound and often involves facial and extraocular muscles. Respiratory failure is nearly uniform, with most individuals requiring 24-hour ventilatory assistance. It is estimated that at least 25% of boys with severe X-MTM die in the first year of life, and those who survive rarely live into adulthood. Males with mild or moderate X-MTM (~20%) achieve motor milestones more quickly than males with the severe form; many ambulate independently, and may live into adulthood. Most require gastrostomy tubes and/or ventilator support. In all subtypes of X-MTM, the muscle disease is not obviously progressive. Female carriers of X-MTM are generally asymptomatic, although manifesting heterozygotes are increasingly being identified. In affected females, symptoms range from severe, generalized weakness presenting in childhood, with infantile onset similar to affected male patients, to mild (often asymmetric) weakness manifesting in adulthood. Affected adult females may experience progressive respiratory decline and ultimately require ventilatory support.</Attribute>
                <XRef ID="NBK1432" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301605</ID>
                <ID Source="BookShelf">NBK1432</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2012">
                <ID Source="PubMed">22617344</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Frase, 2016">
                <URL>http://online.liebertpub.com/doi/10.1089/hum.2016.29024.arf</URL>
              </Citation>
              <XRef ID="596" DB="Orphanet" />
              <XRef ID="C0410203" DB="MedGen" />
              <XRef ID="MONDO:0010683" DB="MONDO" />
              <XRef Type="MIM" ID="310400" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7331349" SubmissionDate="2023-04-04" DateLastUpdated="2023-05-06" DateCreated="2023-05-06">
        <ClinVarSubmissionID localKey="NM_000252.2:c.-76_-11del|OMIM:310400" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV003921981" DateUpdated="2023-05-06" DateCreated="2023-05-06" Type="SCV" Version="1" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>- Non-coding variant with known effect. This 5’UTR variant deletes the transcription start site (TSS) of the canonical transcript. Sequencing of blood derived RNA (in-house, non-accredited) indicates complete loss of transcription initiation from the affected TSS, while transcription is retained in the unaffected parents. There was no indication of significant transcription from an alternative TSS. - Variant is absent from gnomAD (both v2 and v3). - This variant has limited previous evidence of pathogenicity in unrelated individual(s). A deletion of MTM1 Exon 1 has been described in two brothers with myotubular myopathy (PMID 9931531, 12467749), however exact coordinates of the described deletion were not available. - Very strong and specific phenotype match for this individual. A muscle biopsie from the patient has confirmed the clinical diagnosis of myotubular myopathy.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MTM1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000252.2:c.-76_-11del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="310400" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13026601</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7331349" TraitType="Disease" MappingType="XRef" MappingValue="310400" MappingRef="OMIM">
        <MedGen CUI="C0410203" Name="Severe X-linked myotubular myopathy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

